Cumplimiento de vacunación frente a la gripe y el neumococo en pacientes con enfermedad pulmonar obstructiva crónica atendidos en atención primaria en Galicia

Published on Apr 1, 2006in Vacunas
· DOI :10.1016/S1576-9887(06)73181-8
Maria C. Ariñez-Fernandez2
Estimated H-index: 2
(King Juan Carlos University),
Valentín Hernández-Barrera24
Estimated H-index: 24
(King Juan Carlos University)
+ 3 AuthorsRodrigo Jiménez-García28
Estimated H-index: 28
(King Juan Carlos University)
Abstract
Resumen Introduccion Desde el ano 2000 se ofrece en Galicia la vacunacion conjunta de gripe y neumococo a personas con factores de riesgo para ambas vacunas. En este trabajo se describe las coberturas de vacunacion frente a gripe y neumococo en pacientes de enfermedad pulmonar obstructive cronica (EPOC) y se analiza los factores relacionados con el cumplimiento de las recomendaciones de vacunacion. Pacientes y metodos Se ha disenado un estudio descriptivo en el ambito de la atencion primaria en Galicia. La informacion se ha obtenido de la historia clinica de los pacientes y de una entrevista personal. Como variables dependientes se considera la respuesta a las preguntas: «?Se ha vacunado de la gripe en la ultima campana?» y «?Le han administrado la vacuna antineumococica alguna vez en la vida?». Como variables independientes se analizan variables sociodemograficas, sobre el estado de salud y estilos de vida. Resultados Se ha incluido a 690 pacientes en el estudio. El 77% refiere haber recibido ambas vacunas. Los individuos mayores de 64 anos, ex fumadores, con mala percepcion de su estado de salud y mayor antiguedad de la enfermedad se asocian a una mayor probabilidad de estar vacunado. Conclusiones El cumplimiento de las recomendaciones de vacunacion frente a gripe y neumococo en pacientes con EPOC tratados en atencion primaria en Galicia es mayor que entre otros grupos de riesgo en otras poblaciones. No obstante, se deberia implementar nuevas estrategias para mejorar las coberturas entre los pacientes jovenes.
  • References (24)
  • Citations (1)
Cite
References24
Published on Jan 1, 1998in Archivos De Bronconeumologia 2.63
L. Marco Jordán3
Estimated H-index: 3
,
J.C. Martín Berra1
Estimated H-index: 1
+ 2 AuthorsG. Zubillaga Garmendia3
Estimated H-index: 3
El objetivo de este trabajo ha sido la realizacion de un estudio transversal descriptivo sobre la enfermedad pulmonar obstructiva cronica en la poblacion general. Se estudiaron 600 varones con edades comprendidas entre los 40 y 60 anos extraidos de una muestra seleccionada aleatoriamente (el 69,9% de la totalidad; el 76,6% de los sujetos elegibles). Se realizo a cada sujeto un cuestionario, una espirometria y una medicion de CO en aire espirado. El 50,8% eran fumadores si bien solo el 24,8% de l...
41 Citations Source Cite
Published on Apr 14, 2000in Morbidity and Mortality Weekly Report 12.89
Scott A. Harper9
Estimated H-index: 9
,
Keiji Fukuda36
Estimated H-index: 36
+ 2 AuthorsCarolyn B. Bridges49
Estimated H-index: 49
s of the IDSA, 34th Annual Meeting, 1996:48. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacently acquired antibody. J Infect Dis 1980;142:844–9. Schoenbaum SC, Weinstein L. Respiratory infection in pregnancy. Clin Obstet Gynecol 1979;22:293–300. Shahab SZ, Glezen WP. Influenza virus. In: Gonik B, ed. Viral diseases in pregnancy. New York, NY: Springer-Verlag, 1994. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A...
4,004 Citations
Published on May 1, 2002in Chest 7.65
David M. Mannino9
Estimated H-index: 9
(Centers for Disease Control and Prevention)
COPD continues to cause a heavy health and economic burden both in the United States and around the world. Some of the risk factors for COPD are well-known and include smoking, occupational exposures, air pollution, airway hyperresponsiveness, asthma, and certain genetic variations, although many questions, such as why ;126>
467 Citations Source Cite
Published on Nov 1, 1998in Vaccine 3.29
Nicole Guérin3
Estimated H-index: 3
Assessment of immunization coverage is an important part of evaluating an immunization programme and it is a useful aid in programme management and decision making. Coverage assessment should be carried out at the national and district levels. Routine methods currently used in EU countries vary and are not always accurate, and should be validated regularly by specific surveys.
26 Citations Source Cite
Published on Sep 1, 2003in Vaccine 3.29
Rodrigo Jimenez3
Estimated H-index: 3
(King Juan Carlos University),
Amparo Larrauri19
Estimated H-index: 19
+ 3 AuthorsLuis Ignacio Gómez-López1
Estimated H-index: 1
Abstract This study sought to describe influenza vaccination coverages for different Spanish population subgroups, stressing the analysis of vaccination-related factors in subjects aged 50–64 years and estimating the possible beneficial effect of extending universal vaccination to this age group. A total of 6400 surveys, targeting subjects over the age of 16 years and drawn from the 1997 Spanish National Health Survey, were used for study purposes. Influenza coverage was observed to rise signifi...
31 Citations Source Cite
Published on Apr 1, 1999in American Journal of Preventive Medicine 4.13
Roderick Mac Donald2
Estimated H-index: 2
(HealthPartners),
Leslie Baken3
Estimated H-index: 3
(HealthPartners)
+ 1 AuthorsK.L. Nichol4
Estimated H-index: 4
(HealthPartners)
Abstract Objective: To assess the validity of self-reported influenza and pneumococcal vaccination status. Design: Cross-sectional surveys of outpatients aged 65 years or older. Setting: A Veterans Affairs Medical Center (VA) and a community managed care organization (MCO). Both organizations have organized influenza and pneumococcal vaccination programs. Subjects: VA subjects included all elderly respondents to a mailed survey of 500 randomly selected outpatients. MCO subjects included all resp...
344 Citations Source Cite
Published on Feb 1, 1997in Vaccine 3.29
Pekka O. Honkanen10
Estimated H-index: 10
(University of Oulu),
Timo Keistinen1
Estimated H-index: 1
(Oulu University Hospital),
Sirkka-Liisa Kivelä18
Estimated H-index: 18
(Oulu University Hospital)
Abstract We compared the coverage achieved with either an age-based, free-of-charge vaccination program offering influenza vaccine alone or with pneumococcal vaccine with a restricted risk disease-based influenza vaccination program supplemented by self-funded immunization. We also compared two means of informing the public, either using mailed personal reminders or through the mass media only. Forty-one administrative districts with a total of 41500 persons aged 65 years or older participated i...
73 Citations Source Cite
Published on Mar 1, 2003in Vaccine 3.29
Richard Kent Zimmerman9
Estimated H-index: 9
(University of Pittsburgh),
Mahlon Raymund21
Estimated H-index: 21
(University of Pittsburgh)
+ 2 AuthorsMichael J. Fine75
Estimated H-index: 75
(University of Pittsburgh)
Abstract National surveys of adult vaccination indicate moderate self-reported immunization rates in the US, with limited validity data. We compared self-report with medical record abstraction for 820 persons aged ≥66 years from inner-city health centers, Veterans Affairs (VA) outpatient clinics, rural and suburban practices. For influenza vaccine, sensitivity was 98% (95% CI: 96–99%); specificity was 38% (95% CI: 33–43%). For pneumococcal polysaccharide vaccine, sensitivity was 85% (95% CI: 82–...
194 Citations Source Cite
Published on Jan 1, 2001in Archivos De Bronconeumologia 2.63
J.A. Barberà-Mir57
Estimated H-index: 57
,
Germán Peces-Barba21
Estimated H-index: 21
+ 4 AuthorsJosé Luis Viejo Bañuelos21
Estimated H-index: 21
226 Citations Source Cite
Published on Nov 1, 1999in Vaccine 3.29
Willy Peetermans35
Estimated H-index: 35
(Katholieke Universiteit Leuven),
Paul Lacante3
Estimated H-index: 3
(Université catholique de Louvain)
During the first two years following registration of the 23-valent pneumococcal vaccine in Belgium, the numbers of doses administered were 166 and 211 per 10,000 inhabitants, representing a vaccination coverage of nearly 20% of the recommended target population as defined by the High Council for Public Health. The time course of vaccine use showed a seasonal variation with up to 74 and 85% of the doses administered from September through November in 1996 and 1997, respectively. Vaccination pract...
16 Citations Source Cite
Cited By1
Published on Jul 1, 2012in Human Vaccines & Immunotherapeutics 2.23
Juana María Santos-Sancho5
Estimated H-index: 5
(Complutense University of Madrid),
Isabel Jiménez-Trujillo14
Estimated H-index: 14
+ 4 AuthorsRodrigo Jiménez-García28
Estimated H-index: 28
The aim of this study is to compare influenza vaccination coverage among Spaniards aged 40 y or over who suffer from chronic obstructive pulmonary disease (COPD) with those without this illness to identify the factors that influence vaccination uptake among patients with COPD. Data was extracted from the European Health Survey performed in Spain in 2009/10, and analyzed data on 15,355 Spaniards (≥ 40 y of age), of whom 1,309 (8.2% 95%CI 7.7–8.7) had COPD was used. We considered the answer (yes/n...
11 Citations Source Cite